Center-Authored Papers

Filters: Author is Lowe, Kimberly A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Yeasts
Scholler N, Lowe KA, Bergan LA, Kampani AV, Ng V, Forrest RM, Thorpe JD, Gross JA, Garvik BM, Drapkin R et al..  2008.  Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(9):2647-55. Abstract
Washington
Tumor Markers, Biological
Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh MW, Andersen MR, Scholler N, Bergan L, Thorpe J et al..  2008.  Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(9):2480-7. Abstract
Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD et al..  2009.  Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1365-72. Abstract
STAT5 Transcription Factor
Specimen Processing Core Facility
Shared Resources
Scholler N, Lowe KA, Bergan LA, Kampani AV, Ng V, Forrest RM, Thorpe JD, Gross JA, Garvik BM, Drapkin R et al..  2008.  Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(9):2647-55. Abstract
Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD et al..  2009.  Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1365-72. Abstract
Severity of Illness Index
Sensitivity and Specificity
Self Disclosure
SEER Program
Risk Assessment
Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD et al..  2009.  Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1365-72. Abstract
RISK
Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh MW, Andersen MR, Scholler N, Bergan L, Thorpe J et al..  2008.  Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(9):2480-7. Abstract
Reverse Transcriptase Polymerase Chain Reaction